SLC31A1 and Parkinson disease: These data indicate less or no localizations between p62 or Ubiquitin and pS129-α-syn in Ctr1-CKO mice, which suggests that p62 and ubiquitin can successfully target pathological α-syn for cellular degradation, leading to less PD-like symptoms.